Polyoxometalate inhibition of SOX2-mediated tamoxifen resistance in breast cancer
Together, these observations highlight the potential use of PW as a SOX2 inhibitor and the therapeutic relevance of targeting SOX2 to treat tamoxifen-resistant breast cancer.
Authors
- Iskander Aurrekoetxea-Rodríguez (ORCID: https://orcid.org/0000-0001-5294-7798)
- Beñat Artetxe (ORCID: https://orcid.org/0000-0002-7373-4596)
- Juan M. Gutiérrez‐Zorrilla (ORCID: https://orcid.org/0000-0001-8777-8533)
- Isabel Gris-Cárdenas (ORCID: https://orcid.org/0000-0003-3552-8000)
- Irantzu Gorroño‐Etxebarria (ORCID: https://orcid.org/0000-0003-4160-6781)
- Robert Kypta (ORCID: https://orcid.org/0000-0002-2389-310X)
- Miriam Rábano
- María dM Vivanco (ORCID: https://orcid.org/0000-0002-9540-247X)
- So Young Lee (ORCID: https://orcid.org/0000-0003-3130-785X)
- Virginia Gamboa-Aldecoa
- Isabella Ramella-Gal
- Connor Parry
Institutions
- University of the Basque Country (ES)
- CIC bioGUNE (ES)
- Imperial College London (GB)
Publication Details
- Journal
- Cell Communication and Signaling
- Published
- 2024-09-02
- DOI
- https://doi.org/10.1186/s12964-024-01800-w
- Citations
- 4
- Primary Topic
- Chromium effects and bioremediation
- Type
- article
- Field-Weighted Citation Impact
- 1.26
Funders
- Ministerio de Ciencia, Innovación y Universidades
- Eusko Jaurlaritza
- Ministerio de Ciencia e Innovación